Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $3.42 in the prior trading day, Gossamer Bio Inc (NASDAQ: GOSS) closed at $3.32, down -2.92%. In other words, the price has decreased by -$2.92 from its previous closing price. On the day, 2.19 million shares were traded. GOSS stock price reached its highest trading level at $3.43 during the session, while it also had its lowest trading level at $3.3.
Ratios:
Our goal is to gain a better understanding of GOSS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.28 and its Current Ratio is at 3.28.
On July 14, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $11.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $9.Oppenheimer initiated its Outperform rating on June 25, 2024, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 19 ’25 when Milligan Sandra bought 26,050 shares for $1.92 per share. The transaction valued at 50,016 led to the insider holds 58,050 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 768434688 and an Enterprise Value of 791086720. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.44. Its current Enterprise Value per Revenue stands at 17.958 whereas that against EBITDA is -5.163.
Stock Price History:
The Beta on a monthly basis for GOSS is 1.91, which has changed by 3.5418324 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $3.60, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is 26.04%, while the 200-Day Moving Average is calculated to be 81.86%.
Shares Statistics:
The stock has traded on average 3.61M shares per day over the past 3-months and 2871190 shares per day over the last 10 days, according to various share statistics. A total of 231.31M shares are outstanding, with a floating share count of 184.81M. Insiders hold about 20.15% of the company’s shares, while institutions hold 61.74% stake in the company. Shares short for GOSS as of 1763078400 were 24422288 with a Short Ratio of 6.77, compared to 1760486400 on 26759668. Therefore, it implies a Short% of Shares Outstanding of 24422288 and a Short% of Float of 11.219999999999999.
Earnings Estimates
Gossamer Bio Inc (GOSS) is currently under the scrutiny of 6.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.19 and low estimates of -$0.24.
Analysts are recommending an EPS of between -$0.59 and -$0.8 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.59, with 6.0 analysts recommending between -$0.2 and -$1.0.
Revenue Estimates
A total of 8 analysts have provided revenue estimates for GOSS’s current fiscal year. The highest revenue estimate was $49.14M, while the lowest revenue estimate was $34.67M, resulting in an average revenue estimate of $42.19M. In the same quarter a year ago, actual revenue was $114.7M
